Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.
-
Authors
-
-
Bouxsein, Mary L1
-
Eastell, Richard2
-
Liu, Li-Yung3
-
Wu, Lucy A4
-
de Papp, Anne E5
-
Grauer, Andreas6
-
Marin, Fernando7
-
Cauley, Jane A8
-
Bauer, Douglas C9
-
Black, Dennis M4
-
1
Center for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, Boston, MA, USA.
,
(Israel)
-
2
Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.
-
3
California Pacific Medical Center, San Francisco, CA, USA.
-
4
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
-
5
Merck and Co. Inc., Kenilworth, NJ, USA.
-
6
Amgen Inc., Thousand Oaks, CA, USA.
-
7
Lilly Research Centre, Eli Lilly & Co., Surrey, UK.
-
8
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
-
9
Department of Medicine, University of California, San Fransisco, San Francisco, CA, USA.
- Type
- Published Article
- Journal
-
Journal of Bone and Mineral Research
- Publisher
-
Wiley (John Wiley & Sons)
- Publication Date
-
Oct 01, 2019
- Volume
-
34
- Issue
-
10
- Pages
-
1977–1978
- Identifiers
-
DOI: 10.1002/jbmr.3837
-
PMID: 31433861
- Source
-
Medline
- Language
-
English
- License
-
Unknown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 11/01/2019 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/31433861
